|
|
Volumn 293, Issue 21, 2005, Pages 2579-2580
|
|
NSAID studies abound in Cancer Research: Drugs may have niche in prevention and treatment
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ATORVASTATIN;
CELECOXIB;
IBUPROFEN;
INDOMETACIN;
KETOPROFEN;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PIROXICAM;
PROTEIN P21;
PROTEIN P27;
SULINDAC;
ANTINEOPLASTIC AGENT;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ANTINEOPLASTIC ACTIVITY;
CANCER MORTALITY;
CANCER RESEARCH;
CANCER RISK;
CANCER SURVIVAL;
CANCER SUSCEPTIBILITY;
CARDIOVASCULAR DISEASE;
COLON ADENOCARCINOMA;
COLON CARCINOGENESIS;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG SAFETY;
GENE EXPRESSION;
GENETIC SUSCEPTIBILITY;
HUMAN;
INTESTINE CANCER;
LONG TERM CARE;
MOUTH CANCER;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
SMOKING;
SQUAMOUS CELL CARCINOMA;
ANIMAL;
ARTICLE;
CLINICAL TRIAL;
COLON TUMOR;
DIET;
DRUG COMBINATION;
DRUG EFFECT;
GENE EXPRESSION REGULATION;
INTESTINE TUMOR;
MOUTH TUMOR;
RISK;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTICARCINOGENIC AGENTS;
CLINICAL TRIALS;
COLONIC NEOPLASMS;
CYCLOOXYGENASE INHIBITORS;
DIET;
DRUG THERAPY, COMBINATION;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
INTESTINAL NEOPLASMS;
MOUTH NEOPLASMS;
RISK;
SMOKING;
|
|
EID: 19644389638
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.293.21.2579 Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|